We’re pleased to welcome SITC members as an important part of this symposium.
Chicago, IL (PRWEB) September 02, 2013
The 12th International Kidney Cancer Symposium will take place in Chicago on October 25 and 26 at the new Raddison Blu Aqua Hotel. Sponsored by the Kidney Cancer Association (KCA) in cooperation with the Society for Immunotherapy in Cancer (SITC), this annual meeting brings together key individuals and representatives from leading laboratories and centers working with renal cell carcinoma. The 12th International Kidney Cancer Symposium seeks to provide a forum for the exchange of ideas and information that will continue to frame directions for future research and treatment.
KCA CEO Bill Bro says, "We’re pleased to welcome SITC members as an important part of this symposium. Immunotherapy is an area of investigation that holds promise for patients and this adds an exciting new dimension to this meeting."
Meeting objectives include:
- Discussing options for operative and minimally invasive management of localized and metastatic renal cell carcinoma.
- Evaluating the growing body of knowledge regarding clinical, molecular, genetic, and biologic characteristics of renal cell carcinoma.
- Discussing the molecular genetics and biology of renal cancers and assess the effects of targeted therapy for this tumor.
- Defining research directions of novel agents and combinations and standard of care therapy for metastatic renal cell carcinoma.
- Projecting future surgical and medical directions and research in non-metastatic and metastatic disease.
This meeting is directed to medical oncologists, urologists, and scientists involved in the clinical and research aspects of renal cell carcinoma and it has been approved for AMA PRA Category 1 Credit™. Further information and registration information is available online.
KCA is a charitable organization made up of patients, family members, physicians, researchers, and other health professionals globally. It is the world’s first international charity dedicated specifically to the eradication of death and suffering from renal cancers. It is also by far the largest organization of its kind, with members in more than 100 countries.